Carriers of the ApoE ε4 allele are at a greater risk for developing Alzheimer’s disease (AD) and those who do develop AD tend to have a much greater neuropathological disease burden. The gene discussed is APOE; the disease is early-onset autosomal dominant Alzheimer disease.